Cipla, Roche In Court-Ordered Mediation Over India Tarceva Patent
This article was originally published in PharmAsia News
Executive Summary
Cipla and Roche have begun negotiating between themselves their dispute over Roche's India patent for its Tarceva (erlotinib) lung-cancer drug after the Delhi High Court pressured them to mediate.